Your browser doesn't support javascript.
loading
Chemical Space Overlap with Critical Protein-Protein Interface Residues in Commercial and Specialized Small-Molecule Libraries.
Si, Yubing; Xu, David; Bum-Erdene, Khuchtumur; Ghozayel, Mona K; Yang, Baocheng; Clemons, Paul A; Meroueh, Samy O.
Afiliação
  • Si Y; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
  • Xu D; Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
  • Bum-Erdene K; Department of BioHealth Informatics, Indiana University School of Informatics and Computing, Indianapolis, IN, 46202, USA.
  • Ghozayel MK; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
  • Yang B; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
  • Clemons PA; Henan Provincial Key Laboratory of Nanocomposites and Applications, Institute of Nanostructured Functional Materials, Huanghe Science and Technology College, Zhengzhou, Henan, 450006, China.
  • Meroueh SO; Chemical Biology and Therapeutics Science Program, Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.
ChemMedChem ; 14(1): 119-131, 2019 01 08.
Article em En | MEDLINE | ID: mdl-30548204
There is growing interest in the use of structure-based virtual screening to identify small molecules that inhibit challenging protein-protein interactions (PPIs). In this study, we investigated how effectively chemical library members docked at the PPI interface mimic the position of critical side-chain residues known as "hot spots". Three compound collections were considered, a commercially available screening collection (ChemDiv), a collection of diversity-oriented synthesis (DOS) compounds that contains natural-product-like small molecules, and a library constructed using established reactions (the "screenable chemical universe based on intuitive data organization", SCUBIDOO). Three different tight PPIs for which hot-spot residues have been identified were selected for analysis: uPAR⋅uPA, TEAD4⋅Yap1, and CaV α⋅CaV ß. Analysis of library physicochemical properties was followed by docking to the PPI receptors. A pharmacophore method was used to measure overlap between small-molecule substituents and hot-spot side chains. Fragment-like conformationally restricted small molecules showed better hot-spot overlap for interfaces with well-defined pockets such as uPAR⋅uPA, whereas better overlap was observed for more complex DOS compounds in interfaces lacking a well-defined binding site such as TEAD4⋅Yap1. Virtual screening of conformationally restricted compounds targeting uPAR⋅uPA and TEAD4⋅Yap1 followed by experimental validation reinforce these findings, as the best hits were fragment-like and had few rotatable bonds for the former, while no hits were identified for the latter. Overall, such studies provide a framework for understanding PPIs in the context of additional chemical matter and new PPI definitions.
Assuntos
Produtos Biológicos/farmacologia; Bibliotecas de Moléculas Pequenas/farmacologia; Proteínas Adaptadoras de Transdução de Sinal/antagonistas & inibidores; Proteínas Adaptadoras de Transdução de Sinal/química; Proteínas Adaptadoras de Transdução de Sinal/metabolismo; Produtos Biológicos/síntese química; Produtos Biológicos/química; Canais de Cálcio/química; Canais de Cálcio/metabolismo; Proteínas de Ligação a DNA/antagonistas & inibidores; Proteínas de Ligação a DNA/química; Proteínas de Ligação a DNA/metabolismo; Relação Dose-Resposta a Droga; Humanos; Estrutura Molecular; Proteínas Musculares/antagonistas & inibidores; Proteínas Musculares/química; Proteínas Musculares/metabolismo; Fosfoproteínas/antagonistas & inibidores; Fosfoproteínas/química; Fosfoproteínas/metabolismo; Ligação Proteica; Mapeamento de Interação de Proteínas; Receptores de Ativador de Plasminogênio Tipo Uroquinase/antagonistas & inibidores; Receptores de Ativador de Plasminogênio Tipo Uroquinase/química; Receptores de Ativador de Plasminogênio Tipo Uroquinase/metabolismo; Bibliotecas de Moléculas Pequenas/síntese química; Bibliotecas de Moléculas Pequenas/química; Relação Estrutura-Atividade; Fatores de Transcrição de Domínio TEA; Fatores de Transcrição/antagonistas & inibidores; Fatores de Transcrição/química; Fatores de Transcrição/metabolismo; Ativador de Plasminogênio Tipo Uroquinase/antagonistas & inibidores; Ativador de Plasminogênio Tipo Uroquinase/química; Ativador de Plasminogênio Tipo Uroquinase/metabolismo; Proteínas de Sinalização YAP
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Bibliotecas de Moléculas Pequenas Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Bibliotecas de Moléculas Pequenas Idioma: En Ano de publicação: 2019 Tipo de documento: Article